Table 1: Characteristics of studies selected for meta-analysis.
First author/year of publication | Country | Period | People | Loss | Regimen | Outcomes | ||
DOT | SAT | DOT | SAT | |||||
Waley, et al. [21] | Pakistan | 1996-1999 | 497 | 0 | 335 | 162 | Cure/treatment completed: 64.47% (216/335) Default: 29.55% (99/335) Death: 3.88% (13/335) |
Cure/treatment completed: 64.81% (105/162) Default: 32.71% (53/162) Death: 1.85% (3/162) |
Zwarenstein, et al. [22] | South Africa | 1994-1995 | 156 | 0 | 112 | 44 | Cure/treatment completed: 65% (73/112) Default: 29% (33/112) Death: 1.7% (2/112) |
Cure/treatment completed: 59% (26/44) Default: 25% (11/44) Death: 2.7% (1/44) |
Zwarenstein, et al. [23] | South Africa | 2004-2005 | 216 | 0 | 111 | 105 | Cure/treatment completed: 54.05% (60/111) Default: 28.8% (32/111) Death: 0.9% (1/111) |
Cure/treatment completed: 60% (63/105) Default: 28.57% (30/105) Death: 0.95% (1/105) |
Kamolratanakul, et al. [24] | Thailand | 1996-1997 | 836 | 0 | 415 | 422 | Cure/treatment completed: 75.9% (315/415) Default: 6.5% (27/415) Death: 6.2% (26/415) |
Cure/treatment completed: 67% (283/422) Default: 13% (55/422) Death: 4.9% (21/422) |
Falcao [25] | Brazil | 1998-2004 | 1548 | 84 (DOT); 161(SAT) | 218 | 1085 | Cure/treatment completed: 76.5% (167/218) | Cure/treatment completed: 61% (666/1085) |
Gabardo [26] | Brazil | 2003 | 159 | 0 | 113 | 46 | Cure/treatment completed: 86.7% (98/113) Default: 9.8% (11/113) Death: 3.5% (4/113) |
Cure/treatment completed: 87% (40/46) Default: 10.9% (5/46) Death: 2.2% (1/113) |
Vieira, et al. [27] | Brazil | 2003-2005 | 301 | 0 | 153 | 148 | Cure/treatment completed: 93% (143/153) Default: 7% (10/153) |
Cure/treatment completed: 86,5% (128/148) Default: 13.5% (20/148) |
Okanurak, et al. [28] | Thailand | 2004-2005 | 931 | 0 | 432 | 300 | Cure/treatment completed: 78.4% (339/432) Default: 5.3% (23/432) Death: 3.7% (16/432) |
Cure/treatment completed: 84% (252/300) Default: 3% (9/300) Death: 3.6% (11/300) |
Anuwatnonthakate, et al. [29] | Thailand | 2004-2006 | 8031 | 0 | 6625 | 1406 | Cure/treatment completed: 67% (1369/6625) Default: 7% (509/6625) Death: 12% (805/6625) |
Cure/treatment completed: 53% (748/1408) Default: 23% (332/1408) Death: 5% (67/1408) |
Egwaga, et al. [30] | Tanzania | 2006 | 1032 | 0 | 484 | 548 | Cure/treatment completed: 64.5% (312/484) Default: 2.7% (13/484) Death: 12.2% (59/484) |
Cure/treatment completed: 60.9% (334/548) Default: 5.1% (28/548) Death: 16.8% (92/548) |
Moosazade, et al. [31] | Iran | 2004-2010 | 683 | 0 | 362 | 321 | Cure/treatment completed: 92% (333/362) Default: 0.8% (3/362) Death: 3.6% (13/362) |
Cure/treatment completed: 83,2% (267/321) Default: 4.7% (15/321) Death: 5.3% (17/321) |